Methods for identifying modified bases in nucleic acid templates

US12527665B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12527665-B2
Application numberUS-202017003388-A
CountryUS
Kind codeB2
Filing dateAug 26, 2020
Priority dateDec 11, 2008
Publication dateJan 20, 2026
Grant dateJan 20, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods, compositions, and systems are provided for characterization of modified nucleic acids. In certain preferred embodiments, single molecule sequencing methods are provided for identification of modified nucleotides within nucleic acid sequences. Modifications detectable by the methods provided herein include chemically modified bases, enzymatically modified bases, abasic sites, non-natural bases, secondary structures, and agents bound to a template nucleic acid.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for identifying one or more modified bases in a nucleic acid template, the method comprising: a) providing a circular nucleic acid template that may have one or more modified bases; b) providing a polymerase enzyme having strand displacement activity and capable of processing the circular nucleic acid template; c) contacting the circular nucleic acid template with the polymerase enzyme; d) monitoring processing of the circular nucleic acid template by the polymerase enzyme, wherein the polymerase enzyme makes multiple passes around the circular nucleic acid template, whereby the processing results in the synthesis of a nascent nucleic acid strand, and wherein the monitoring: (i) occurs during the processing, and (ii) detects incorporation of single nucleotides into the nascent nucleic acid strand, thereby generating multiple sequence reads complementary to the circular nucleic acid template; e) measuring the kinetics of single nucleotide incorporations; and f) identifying, if present, one or more modified bases within the circular nucleic acid template using the measured kinetics of nucleotide incorporations for the multiple sequence reads. 2 . The method of claim 1 , wherein the identifying includes using kinetic measurements for nucleotides incorporated upstream and downstream of the one or more modified bases in the nucleic acid template. 3 . The method of claim 1 , wherein the kinetic measurements include interpulse duration (IPD) or pulse width (PW). 4 . The method of claim 1 , wherein the kinetic measurements include interpulse duration (IPD) and pulse width (PW). 5 . The method of claim 1 , wherein the kinetic measurements from the multiple sequence reads are averaged. 6 . The method of claim 1 , wherein the polymerase makes 3 or more passes around the circular nucleic acid template. 7 . The method of claim 1 , wherein the polymerase makes 5 or more passes around the circular nucleic acid template. 8 . The method of claim 1 , wherein the circular nucleic acid template comprises a double-stranded nucleic acid capped with hairpins. 9 . The method of claim 8 , wherein the hairpins comprise barcodes. 10 . The method of claim 1 , wherein the one or more modified bases include a methylated cytosine or a methylated adenine base. 11 . The method of claim 1 , wherein the one or more modified bases include 5-methyl cytosine. 12 . The method of claim 1 , wherein the one or more modified bases include 5-hydroxymethyl cytosine. 13 . The method of claim 1 , wherein the circular nucleic acid template comprises DNA. 14 . The method of claim 1 , wherein the circular nucleic acid template is DNA. 15 . The method of claim 1 , wherein prior to providing the circular nucleic acid template, the nucleic acid template is subjected to a treatment to alter a modified base of the one or more modified bases. 16 . The method of claim 15 , wherein the treatment is selected from the group consisting of: glycosylase modification, DMS modification, cytosine methyltransferase modification, TET 1 modification, restriction enzyme modification, and cytidine deaminase modification. 17 . The method of claim 1 , wherein the polymerase enzyme is immobilized at optically resolvable reaction sites on a substrate during the monitoring. 18 . The method of claim 1 , wherein the circular nucleic acid template comprises regions of internal complementarity. 19 . The method of claim 18 , wherein the regions of internal complementarity are used to map positions of modified bases in the nucleic acid template.

Assignees

Inventors

Classifications

  • ICT specially adapted for sequence analysis involving nucleotides or amino acids · CPC title

  • Methods for sequencing · CPC title

  • differing in thickness · CPC title

  • having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis · CPC title

  • spherical · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12527665B2 cover?
Methods, compositions, and systems are provided for characterization of modified nucleic acids. In certain preferred embodiments, single molecule sequencing methods are provided for identification of modified nucleotides within nucleic acid sequences. Modifications detectable by the methods provided herein include chemically modified bases, enzymatically modified bases, abasic sites, non-natura…
Who is the assignee on this patent?
Pacific Biosciences California Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/30721. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).